| 翻訳と辞書 |
| Tute Genomics ： ウィキペディア英語版 |
Tute Genomics
Tute Genomics is a genomics startup that provides a cloud-based web application for rapid and accurate annotation of human genomic data. Built on the expertise of ANNOVAR, Tute assists researchers in identifying disease genes and biomarkers, and assists clinicians/labs in performing genetic diagnosis.〔(【引用サイトリンク】url=http://www.bio-itworld.com/2015/1/6/david-mittelman-joins-tute-genomics.html )〕 Based in Provo, Utah, Tute was co-founded by ''Dr. Kai Wang'', an Assistant Professor at the University of Southern California (USC); and ''Dr. Reid J. Robison'' a board-certified psychiatrist, with fellowship training in both neurodevelopmental genetics and bioinformatics.〔(【引用サイトリンク】url=http://investing.businessweek.com/Research/stocks/private/person.asp?personId=252520190&privcapId=249882925&previousCapId=249882925&previousTitle=Tute%20Genomics,%20Inc. )〕
The word ''“tute”'' means “personal” in the Na’vi language created for the movie Avatar by Paul Frommer, a professor at the USC Marshall School of Business.〔(【引用サイトリンク】url=https://www.genomeweb.com/informatics/startup-tute-genomics-launches-cloud-based-variant-annotation-and-interpretation )〕
==History==
Tute Genomics launched in 2013 and entered the accelerator, ''BoomStartup''. By “demo day” of BoomStartup, Tute had raised their seed round of funding and expanded the round to include ''angel investors'' from ''SLC Angels'', ''Park City Angels'', ''Life Science Angels''. Tute was the 10th ever online syndicate for AngelList and in all raised a seed round of $1.5M. The company announced a Series A1 funding round of $2.3 million in December 2014. The round was led by UK-based Eurovestech. Peak Ventures and a number of angel investors also participated in this round.〔(【引用サイトリンク】url=http://venturebeat.com/2014/12/04/tute-genomics-raises-2-3m-for-genome-analytics-platform/ )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Tute Genomics」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|